Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Ginkgo Bioworks Holdings, Inc. (DNA) had Free Cash Flow per Share of $-1.54 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$20.16M |
|
$-46.71M |
|
$1.72M |
|
$18.44M |
|
$78.70M |
|
$-58.55M |
|
$1.35M |
|
$-57.19M |
|
$-59.18M |
|
$-57.32M |
|
$-57.32M |
|
$-46.71M |
|
$-59.30M |
|
$-58.55M |
|
$-46.23M |
|
62.09M |
|
62.09M |
|
$-0.75 |
|
$-0.75 |
|
| Balance Sheet Financials | |
$332.54M |
|
$157.19M |
|
$657.51M |
|
$990.05M |
|
$72.74M |
|
-- |
|
$497.02M |
|
$569.76M |
|
$420.28M |
|
$375.90M |
|
$420.28M |
|
63.71M |
|
| Cash Flow Statement Financials | |
$-90.96M |
|
$34.22M |
|
$16.47M |
|
$212.37M |
|
$172.01M |
|
$-40.36M |
|
$23.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.57 |
|
-- |
|
-- |
|
-- |
|
-- |
|
91.47% |
|
-290.47% |
|
-290.47% |
|
-- |
|
-283.75% |
|
-231.74% |
|
$-95.51M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
1.55 |
|
58.11 |
|
-13.64% |
|
-15.25% |
|
-5.79% |
|
-13.64% |
|
$6.60 |
|
|
Free Cash Flow per Share |
$-1.54 |
$-1.46 |
|